Vogt Frederick G
Vogt Frederick G, IC, GC, reported a transaction classified as exercise at IOVANCE BIOTHERAPEUTICS, INC. involving 15626.000000 shares for an estimated $0.00. Reported holdings after the transaction were 93756.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
IOVA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001104659-26-106752 Restricted Stock Units
- Transaction date
- Sep 08, 2026 Filed Sep 10, 2026, 09:01 PM · 2d delay
- Shares
- 15,626 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 93,756 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Interim CEO & General Counsel
- F1
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- F2
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- F3
Represents common stock remaining after deducting the common stock withheld for taxes.
- F4
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5
The remaining RSUs will vest in equal quarterly installments.
- F6
Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.
0 other transactions
0 recent txs